Adjuvant De-Escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer

Clinical trial NCT03715946 · COMPLETED

Trial details

NCT number: NCT03715946
Sponsor: Robert L. Ferris, MD, PhD
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Squamous Cell of Head and Neck Oropharynx Squamous Cell Carcinoma

Start date: 2018-11-16
Primary completion: 2023-03-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.